AU2003267475A1 - Tumor targeting agents and uses thereof - Google Patents

Tumor targeting agents and uses thereof

Info

Publication number
AU2003267475A1
AU2003267475A1 AU2003267475A AU2003267475A AU2003267475A1 AU 2003267475 A1 AU2003267475 A1 AU 2003267475A1 AU 2003267475 A AU2003267475 A AU 2003267475A AU 2003267475 A AU2003267475 A AU 2003267475A AU 2003267475 A1 AU2003267475 A1 AU 2003267475A1
Authority
AU
Australia
Prior art keywords
targeting agents
tumor targeting
tumor
agents
targeting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003267475A
Inventor
Merja Auvinen
Mathias Bergman
Hannu Elo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KARYON Oy
Original Assignee
KARYON Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KARYON Oy filed Critical KARYON Oy
Publication of AU2003267475A1 publication Critical patent/AU2003267475A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003267475A 2002-10-03 2003-10-03 Tumor targeting agents and uses thereof Abandoned AU2003267475A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20021760 2002-10-03
FI20021760A FI20021760A0 (en) 2002-10-03 2002-10-03 New therapeutic / diagnostic substances and preparations and their applications
PCT/FI2003/000725 WO2004031220A1 (en) 2002-10-03 2003-10-03 Tumor targeting agents and uses thereof

Publications (1)

Publication Number Publication Date
AU2003267475A1 true AU2003267475A1 (en) 2004-04-23

Family

ID=8564693

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003267475A Abandoned AU2003267475A1 (en) 2002-10-03 2003-10-03 Tumor targeting agents and uses thereof

Country Status (3)

Country Link
AU (1) AU2003267475A1 (en)
FI (1) FI20021760A0 (en)
WO (1) WO2004031220A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110118816B (en) * 2018-02-05 2021-07-27 中国科学院化学研究所 Method for detecting biodistribution of nano drug-loaded system in organism
IT202100023357A1 (en) 2021-09-09 2023-03-09 Cheirontech S R L Peptides with anti-angiogenic activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981478A (en) * 1993-11-24 1999-11-09 La Jolla Cancer Research Foundation Integrin-binding peptides
US5622699A (en) * 1995-09-11 1997-04-22 La Jolla Cancer Research Foundation Method of identifying molecules that home to a selected organ in vivo
GB0029407D0 (en) * 2000-12-01 2001-01-17 Affitech As Product

Also Published As

Publication number Publication date
FI20021760A0 (en) 2002-10-03
WO2004031220A1 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
AUPS054702A0 (en) Cancer therapy
AU2003215460A1 (en) Cancer associated protein kinases and their uses
AU2003274355A1 (en) Targeted delivery
AU2002952993A0 (en) Therapeutic and diagnostic agents
AU2003294318A1 (en) Therapeutic bioconjugates
AU2003247005A1 (en) Therapy combination
AU2003245794A1 (en) Glycosaminoglycan-dnase combination therapy
AU2003205381A1 (en) Hpma-polyamine conjugates and uses therefore
AU2003212162A1 (en) Cancer associated protein phosphatases and their uses
AU2002334891A1 (en) Tumor targeted photodiagnostic-phototherapeutic agents
AU2002335667A1 (en) Modified reoviral therapy
AU2003251513A1 (en) Rsk inhibitors and therapeutic uses thereof
AU2003281691A1 (en) Furoisoquinoline derivative and use thereof
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2003900495A0 (en) Aroylhydrazone derivatives and therapeutic uses thereof
AU2003283339A1 (en) Cancer therapy determination
AU2003267475A1 (en) Tumor targeting agents and uses thereof
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003240052A1 (en) Il-11 derivatives and therapeutic uses thereof
AU2003228397A1 (en) HAUSP-p53 INTERACTION AND USES THEREOF
AUPS243002A0 (en) Therapeutic target and uses thereof
AU2002335297A1 (en) Tumor tag and the use thereof
AU2002953516A0 (en) Genetic therapy and genetic modification
AU2003216442A1 (en) Enkurin and uses thereof
AU2002952657A0 (en) Therapeutic agents and uses therefor-II

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase